UniProt ID | FANCE_HUMAN | |
---|---|---|
UniProt AC | Q9HB96 | |
Protein Name | Fanconi anemia group E protein | |
Gene Name | FANCE | |
Organism | Homo sapiens (Human). | |
Sequence Length | 536 | |
Subcellular Localization | Nucleus . | |
Protein Description | As part of the Fanconi anemia (FA) complex functions in DNA cross-links repair. Required for the nuclear accumulation of FANCC and provides a critical bridge between the FA complex and FANCD2.. | |
Protein Sequence | MATPDAGLPGAEGVEPAPWAQLEAPARLLLQALQAGPEGARRGLGVLRALGSRGWEPFDWGRLLEALCREEPVVQGPDGRLELKPLLLRLPRICQRNLMSLLMAVRPSLPESGLLSVLQIAQQDLAPDPDAWLRALGELLRRDLGVGTSMEGASPLSERCQRQLQSLCRGLGLGGRRLKSPQAPDPEEEENRDSQQPGKRRKDSEEEAASPEGKRVPKRLRCWEEEEDHEKERPEHKSLESLADGGSASPIKDQPVMAVKTGEDGSNLDDAKGLAESLELPKAIQDQLPRLQQLLKTLEEGLEGLEDAPPVELQLLHECSPSQMDLLCAQLQLPQLSDLGLLRLCTWLLALSPDLSLSNATVLTRSLFLGRILSLTSSASRLLTTALTSFCAKYTYPVCSALLDPVLQAPGTGPAQTELLCCLVKMESLEPDAQVLMLGQILELPWKEETFLVLQSLLERQVEMTPEKFSVLMEKLCKKGLAATTSMAYAKLMLTVMTKYQANITETQRLGLAMALEPNTTFLRKSLKAALKHLGP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
84 | Ubiquitination | PDGRLELKPLLLRLP CCCCEEHHHHHHHHH | 25.01 | 21890473 | |
101 | Ubiquitination | CQRNLMSLLMAVRPS HHHHHHHHHHHHCCC | 2.06 | 22817900 | |
104 | Ubiquitination | NLMSLLMAVRPSLPE HHHHHHHHHCCCCCC | 8.30 | 22817900 | |
116 | Ubiquitination | LPESGLLSVLQIAQQ CCCCCHHHHHHHHHH | 26.31 | 24816145 | |
142 | Dimethylation | ALGELLRRDLGVGTS HHHHHHHHHCCCCCC | 43.40 | - | |
148 | Phosphorylation | RRDLGVGTSMEGASP HHHCCCCCCCCCCCC | 23.61 | 23532336 | |
154 | Phosphorylation | GTSMEGASPLSERCQ CCCCCCCCCHHHHHH | 36.91 | 21815630 | |
157 | Phosphorylation | MEGASPLSERCQRQL CCCCCCHHHHHHHHH | 26.78 | 23532336 | |
159 | Dimethylation | GASPLSERCQRQLQS CCCCHHHHHHHHHHH | 20.63 | - | |
162 | Ubiquitination | PLSERCQRQLQSLCR CHHHHHHHHHHHHHH | 42.68 | 22817900 | |
166 | Phosphorylation | RCQRQLQSLCRGLGL HHHHHHHHHHHHCCC | 37.72 | 24719451 | |
174 | Ubiquitination | LCRGLGLGGRRLKSP HHHHCCCCCCCCCCC | 26.26 | 22817900 | |
180 | Phosphorylation | LGGRRLKSPQAPDPE CCCCCCCCCCCCCHH | 27.17 | 30266825 | |
194 | Phosphorylation | EEEENRDSQQPGKRR HHHCCCCCCCCCCCC | 27.72 | 28985074 | |
199 | Ubiquitination | RDSQQPGKRRKDSEE CCCCCCCCCCCCHHH | 56.57 | 21906983 | |
202 | Ubiquitination | QQPGKRRKDSEEEAA CCCCCCCCCHHHHHC | 70.42 | 22817900 | |
204 | Phosphorylation | PGKRRKDSEEEAASP CCCCCCCHHHHHCCC | 50.36 | 23401153 | |
210 | Phosphorylation | DSEEEAASPEGKRVP CHHHHHCCCCCCCCC | 30.45 | 23401153 | |
214 | Ubiquitination | EAASPEGKRVPKRLR HHCCCCCCCCCCHHC | 48.86 | 24816145 | |
238 | Phosphorylation | KERPEHKSLESLADG CCCCCCCCHHHHCCC | 39.00 | 29255136 | |
241 | Phosphorylation | PEHKSLESLADGGSA CCCCCHHHHCCCCCC | 33.86 | 23401153 | |
247 | Phosphorylation | ESLADGGSASPIKDQ HHHCCCCCCCCCCCC | 30.97 | 23401153 | |
249 | Phosphorylation | LADGGSASPIKDQPV HCCCCCCCCCCCCCE | 28.93 | 19664994 | |
252 | Ubiquitination | GGSASPIKDQPVMAV CCCCCCCCCCCEEEE | 54.41 | 29967540 | |
260 | Ubiquitination | DQPVMAVKTGEDGSN CCCEEEEEECCCCCC | 41.07 | 21906983 | |
261 | Phosphorylation | QPVMAVKTGEDGSNL CCEEEEEECCCCCCH | 38.92 | 26074081 | |
266 | Phosphorylation | VKTGEDGSNLDDAKG EEECCCCCCHHHHCH | 46.68 | 26074081 | |
272 | Ubiquitination | GSNLDDAKGLAESLE CCCHHHHCHHHHHCC | 62.54 | 22817900 | |
272 | Methylation | GSNLDDAKGLAESLE CCCHHHHCHHHHHCC | 62.54 | - | |
282 | Ubiquitination | AESLELPKAIQDQLP HHHCCHHHHHHHHHH | 71.40 | 29967540 | |
346 | Phosphorylation | LGLLRLCTWLLALSP HHHHHHHHHHHHHCC | 24.60 | 18995830 | |
374 | Phosphorylation | LFLGRILSLTSSASR HHHHHHHHHCHHHHH | 27.51 | 17924555 | |
378 | Phosphorylation | RILSLTSSASRLLTT HHHHHCHHHHHHHHH | 25.65 | 28674151 | |
380 | Phosphorylation | LSLTSSASRLLTTAL HHHCHHHHHHHHHHH | 25.96 | 28674151 | |
484 | Phosphorylation | CKKGLAATTSMAYAK HHCCCHHHHHHHHHH | 17.50 | 21406692 | |
485 | Phosphorylation | KKGLAATTSMAYAKL HCCCHHHHHHHHHHH | 16.27 | 21406692 | |
486 | Phosphorylation | KGLAATTSMAYAKLM CCCHHHHHHHHHHHH | 9.32 | 21406692 | |
489 | Phosphorylation | AATTSMAYAKLMLTV HHHHHHHHHHHHHHH | 8.81 | 21406692 | |
495 | Phosphorylation | AYAKLMLTVMTKYQA HHHHHHHHHHHHHHC | 8.35 | 22210691 | |
500 | Phosphorylation | MLTVMTKYQANITET HHHHHHHHHCCCCHH | 12.05 | 28796482 | |
505 | Phosphorylation | TKYQANITETQRLGL HHHHCCCCHHHHHHH | 32.55 | 22210691 | |
507 | Phosphorylation | YQANITETQRLGLAM HHCCCCHHHHHHHHH | 15.44 | 28796482 | |
520 | Phosphorylation | AMALEPNTTFLRKSL HHHCCCCCHHHHHHH | 29.64 | 28796482 | |
521 | Phosphorylation | MALEPNTTFLRKSLK HHCCCCCHHHHHHHH | 27.58 | 28796482 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FANCE_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
600901 | Fanconi anemia complementation group E (FANCE) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249, AND MASSSPECTROMETRY. |